Rory E Morty Selected Research

delta-hydroxylysylnorleucine

6/2015	Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia.
7/2014	Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rory E Morty Research Topics

Disease

18	Bronchopulmonary Dysplasia 01/2021 - 02/2007
15	Hyperoxia 12/2022 - 02/2007
13	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 03/2005
11	Edema (Dropsy) 12/2021 - 03/2005
9	Infections 04/2022 - 03/2005
9	Inflammation (Inflammations) 01/2021 - 02/2012
7	Acute Lung Injury 11/2017 - 07/2007
7	Pulmonary Arterial Hypertension 07/2014 - 05/2007
6	Lung Injury 12/2022 - 05/2008
5	Hypoxia (Hypoxemia) 01/2020 - 04/2006
4	COVID-19 01/2022 - 01/2020
4	Hypercapnia 12/2021 - 01/2017
4	Premature Birth (Birth, Premature) 01/2021 - 01/2017
4	Lung Diseases (Lung Disease) 10/2020 - 12/2009
3	Vascular Diseases (Vascular Disease) 12/2022 - 11/2007
3	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2015
3	Vascular Remodeling 07/2014 - 10/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 02/2014 - 12/2009
3	African Trypanosomiasis (Nagana) 01/2013 - 04/2005
2	Asthma (Bronchial Asthma) 04/2022 - 02/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 12/2020 - 08/2017
2	Critical Illness (Critically Ill) 01/2020 - 04/2014
2	Right Ventricular Hypertrophy 01/2020 - 07/2014
2	Pneumonia (Pneumonitis) 01/2018 - 03/2014
2	Neoplasms (Cancer) 08/2017 - 10/2011
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2017 - 10/2011
2	Familial Primary Pulmonary Hypertension 07/2014 - 11/2007
2	Pulmonary Hypertension 07/2014 - 09/2010
2	Fibrosis (Cirrhosis) 02/2014 - 12/2009
2	Parasitic Diseases (Parasitic Disease) 03/2006 - 07/2002
1	Cystic Fibrosis (Mucoviscidosis) 04/2022
1	Hypersensitivity (Allergy) 04/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	IgG Deficiency 01/2021
1	Alopecia (Baldness) 12/2020
1	Ventilator-Induced Lung Injury 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Heart Failure 01/2019

Drug/Important Bio-Agent (IBA)

10	Oxygen (Dioxygen)IBA 01/2021 - 10/2006
8	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2006
7	Adenosine Triphosphatases (ATPase)IBA 12/2021 - 10/2005
6	CollagenIBA 01/2020 - 03/2011
4	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2022 - 02/2007
4	EnzymesIBA 12/2021 - 07/2014
4	Transforming Growth Factor beta (TGF-beta)IBA 12/2009 - 02/2007
3	Bone Morphogenetic Protein ReceptorsIBA 12/2022 - 05/2007
3	SmokeIBA 12/2022 - 03/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 10/2006
3	LigandsIBA 01/2018 - 01/2013
3	Bleomycin (Blenoxane)FDA LinkGeneric 11/2017 - 10/2011
3	MonocrotalineIBA 07/2014 - 05/2007
3	oligopeptidase BIBA 01/2013 - 06/2002
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2009 - 02/2007
3	Peptide Hydrolases (Proteases)FDA Link 07/2007 - 06/2002
3	Virulence Factors (Pathogenicity Factors)IBA 03/2006 - 06/2002
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2022 - 01/2019
2	Small Interfering RNA (siRNA)IBA 12/2021 - 04/2006
2	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 12/2020 - 02/2014
2	Carbon DioxideIBA 01/2020 - 01/2017
2	Fibroblast Growth Factor 10IBA 01/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018 - 11/2007
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2018 - 07/2014
2	Oxidoreductases (Dehydrogenase)IBA 08/2017 - 07/2014
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2017 - 01/2016
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 06/2015 - 07/2014
2	AminopropionitrileIBA 06/2015 - 07/2014
2	delta-hydroxylysylnorleucineIBA 06/2015 - 07/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 05/2008
2	Pancreatic Elastase (Elastase)IBA 09/2011 - 03/2011
2	Serine (L-Serine)FDA Link 03/2005 - 06/2002
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Inositol (Myoinositol)IBA 12/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	UbiquitinIBA 01/2021
1	Minoxidil (Rogaine)FDA LinkGeneric 12/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2020
1	Nicotine FDA Link 10/2020
1	Membrane Transport Proteins (Biological Pump)IBA 02/2020
1	Cell Adhesion MoleculesIBA 02/2020
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 02/2020
1	Adenosine Triphosphate (ATP)IBA 02/2020
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2020
1	AntioxidantsIBA 01/2019
1	ChemokinesIBA 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 11/2018

Therapy/Procedure

7	Therapeutics 01/2021 - 02/2007
6	Artificial Respiration (Mechanical Ventilation) 12/2022 - 01/2015
2	Critical Care (Surgical Intensive Care) 04/2022 - 07/2007
1	Length of Stay 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020